Trademark: 97485027
Word
ODAWNLY
Status Date
Tuesday, June 18, 2024
Filing Date
Friday, July 1, 2022
Published for Opposition
Tuesday, April 25, 2023
5 Pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
Jan 10, 2023
Non-Final Action Written
Jul 5, 2022
New Application Entered
Jul 21, 2022
New Application Office Supplied Data Entered
Jan 3, 2023
Assigned To Examiner
Jan 10, 2023
Non-Final Action E-Mailed
Jan 10, 2023
Notification Of Non-Final Action E-Mailed
Mar 6, 2023
Teas Response To Office Action Received
Mar 6, 2023
Correspondence Received In Law Office
Mar 6, 2023
Teas/Email Correspondence Entered
Mar 20, 2023
Approved For Pub - Principal Register
Apr 5, 2023
Notification Of Notice Of Publication E-Mailed
Apr 25, 2023
Published For Opposition
Apr 25, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2024
Sou Teas Extension Received
Jun 18, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2024
Sou Extension 2 Granted
Jun 18, 2024
Sou Extension 2 Filed
Dec 5, 2023
Sou Extension 1 Granted
Dec 5, 2023
Sou Teas Extension Received
Dec 5, 2023
Sou Extension 1 Filed
Trademark Alertz updated from USPTO on 2030-01-24
